US Patent Issued to Howard University on Aug. 12 for "Methods for treating triple negative breast cancer using salvianolic acid B" (District Of Columbia Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,527, issued on Aug. 12, was assigned to Howard University (Washington).

"Methods for treating triple negative breast cancer using salvianolic acid B" was invented by Xinbin Gu (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods related to treating triple-negative breast cancer (TNBC) in a mammal by administering salvianolic acid B (or a salt or solvate thereof) to promote ceramide-mediated apoptosis. In one form, the ceramide-mediated apoptosis of TNBC cells occurs by decreasing the level of one or more of glucosylceramide synthase and GM3 synthase in the subject through the use of an effective amount o...